About us
Introduction
Quality forum
Medicines UK structure
Medicines UK executive team
Our members
Associate members
Disclosure
Our core focus
Patients
Quality
Value
Sustainability
Partnership
Key issues
Introduction
Generic Pricing
Benefits to the NHS
Current supply issues
Patient access
Patient information
Freedom in market pricing
Getting to market
Sustainability
MHRA performance
Better Patent Regulation
Biosimilars
Falsified Medicines Directive
Industry-NHS guidance
About generics
Introduction
Industry overview
The generics industry
Studies on the generic medicines market in the UK
Generics FAQs
News
Current news
Information
Join us
Introduction
Associate Membership
Associate Members
Contact us
About us
Introduction
Quality forum
Medicines UK structure
Medicines UK executive team
Our members
Associate members
Disclosure
Our core focus
Patients
Quality
Value
Sustainability
Partnership
Key issues
Introduction
Generic Pricing
Benefits to the NHS
Current supply issues
Patient access
Patient information
Freedom in market pricing
Getting to market
Sustainability
MHRA performance
Better Patent Regulation
Biosimilars
Falsified Medicines Directive
Industry-NHS guidance
About generics
Introduction
Industry overview
The generics industry
Studies on the generic medicines market in the UK
Generics FAQs
News
Current news
Information
Join us
Introduction
Associate Membership
Associate Members
Contact us
Biosimilars
Current news
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2023
18.12.2023
Medicines UK supply issue dashboard December 2023
05.12.2023
Viatris Country Manager elected UK Trade Association, Medicines UK, Vice-Chair
31.10.2023
Medicines UK supply issue dashboard October 2023
21.11.2023
VPAG Heads of Agreement Reaction
06.11.2023
Spiralling VPAS rebate starts to bite as record number of medicines face supply issues
30.10.2023
"Spiralling" Government tax threatens to add millions to local NHS budgets
11.10.2023
Statutory Scheme Consultation Response
01.09.2023
Medicines UK supply issue dashboard September 2023
15.08.2023
NEW REPORT: NHS Set to Miss Out on Vital Biologic Medicine Savings in the Next Five Years
03.08.2023
Statutory Scheme Response
17.07.2023
Medicines UK supply issue dashboard July 2023
10.07.2023
Medicines UK Warns of Significant Implications From Crippling VPAS Rate
15.06.2023
Medicines UK supply issue dashboard June 2023
15.06.2023
Delivering a financially sustainable VPAS that supports widened medicines access to patients: Medicines UK's position for the 2024-2028 VPAS negotiations
15.06.2023
Billions of pounds of NHS savings under threat from rising Government tax
03.05.2023
Medicines UK supply issue dashboard May 2023
15.05.2023
Medicines UK Elects New Association Vice Chair
21.04.2023
VPAS Update - Judicial Review
03.03.2023
Medicines UK supply issue dashboard March 2023
28.02.2023
Statement on Northern Ireland Protocol
06.01.2023
Medicines UK supply issue dashboard January 2023
Highlights
18.12.2023
Medicines UK supply issue dashboard December 2023
05.12.2023
Viatris Country Manager elected UK Trade Association, Medicines UK, Vice-Chair
31.10.2023
Medicines UK supply issues dashboard October 2023
21.11.2023
VPAG Heads of Agreement Reaction
06.11.2023
Spiralling VPAS rebate starts to bite as record number of medicines face supply issues
30.10.2023
"Spiralling" Government tax threatens to add millions to local NHS budgets
11.10.2023
Statutory Scheme Consultation Response
01.09.2023
Medicines UK supply issue dashboard September 2023